Follow-Up Extension Study of a Double-Blind Phase 3 Clinical Study of Recombinant Human Arylsulfatase B in Patients with Mucopolysaccharidosis Vi

AuthID
P-000-4KE
10
Author(s)
Harmatz, P
·
Giugliani, R
·
Schwartz, I
·
Guffon, N
·
Teles, E
·
Wraith, JE
·
Beck, M
·
Hopwood, J
·
Swiedler, S
Document Type
Abstract
Year published
2005
Published
in MOLECULAR GENETICS AND METABOLISM, ISSN: 1096-7192
Volume: 84, Issue: 3, Pages: 237-238 (2)
Conference
Annual Meeting of the Society-For-Inherited-Metabolic-Disorders (Simd 2005), Date: MAR 06-09, 2005, Location: Pacific Grove, CA, Sponsors: Genzyme Corp, Mead Johnson Nutr, NIDDK, NIH, Off Rare Dis, Dept Hlth & Human Serv, Ucyclyd Pharma, Actelion Pharmaceut US Inc, Abbott Labs, Ross Prod Div, SHS N Amer, Appl Biosyst, Appl Nutr Corp, BioMarin Pharmaceut Inc, Milupa N Amer, Vitaflo, Biochrom Inc, Cambrooke Foods, Hitachi High Technologies Amer Inc, Natl Urea Cycle Defects Fdn, Pickering Labs Inc, Rare Dis Therapeut Inc, Sigma Tau Pharmaceut, Transkarot Therapies Inc
Indexing
Publication Identifiers
Wos: WOS:000227648400101
Source Identifiers
ISSN: 1096-7192
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.